No Data
GlycoMimetics GAAP EPS of -$0.17 In-line
GlycoMimetics | 10-Q: Quarterly report
GlycoMimetics, Inc. (GLYC) Corporate Update Call Transcript
GlycoMimetics, Inc. (GLYC) Corporate Update Call Transcript
Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50
Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50.
Express News | GlycoMimetics Inc : Jefferies Cuts Target Price to $1 From $3
GlycoMimetics Announces Promising Phase 3 Leukemia Drug Results